CHRIS AMOS to Cyclin-Dependent Kinase Inhibitor p27
This is a "connection" page, showing publications CHRIS AMOS has written about Cyclin-Dependent Kinase Inhibitor p27.
Connection Strength
0.154
-
Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study. Pancreas. 2010 Jan; 39(1):1-4.
Score: 0.080
-
Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. Ann Surg Oncol. 2009 Feb; 16(2):431-9.
Score: 0.074